Journey Medical Corporation (DERM)
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
$112.96M
Mr. Claude Maraoui
90.00
Scottsdale, AZ
Nov 12, 2021
41.92
$0.13
0.70
1.36
0.76%
1.09%
132.34
3.52
9.88
1.49
1.08
1.29%
5.44%
Similar stocks (7)
Curaleaf Holdings, Inc.
CURLF
Cresco Labs Inc.
CRLBF
Organogenesis Holdings Inc.
ORGO
Aquestive Therapeutics, Inc.
AQST
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Evoke Pharma, Inc.
EVOK
ETF Exposure (3)
iShares Micro-Cap ETF
IWC
0.01001%
Dimensional US Sustainability Core 1 ETF
DFSU
9.4279e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.455e-5%
Similar stocks (7)
Curaleaf Holdings, Inc.
CURLF
Cresco Labs Inc.
CRLBF
Organogenesis Holdings Inc.
ORGO
Aquestive Therapeutics, Inc.
AQST
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Evoke Pharma, Inc.
EVOK
ETF Exposure (3)
iShares Micro-Cap ETF
IWC
0.01001%
Dimensional US Sustainability Core 1 ETF
DFSU
9.4279e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.455e-5%